Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multifaceted role for p53 in pancreatic cancer suppression
Stephano S. Mello, Brittany M. Flowers, Paweł K. Mazur, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 10
Open Access | Times Cited: 23

Showing 23 citing articles:

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
Dimitrios Stefanoudakis, Maximos Frountzas, Dimitriοs Schizas, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 2827-2844
Open Access | Times Cited: 23
Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer
Louis Marstrand-Daucé, Diane Lorenzo, Anaïs Chassac, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9946-9946
Open Access | Times Cited: 23
Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control?
Ana Janic, Etna Abad, Ivano Amelio
Cell Death and Differentiation (2024)
Open Access | Times Cited: 10
Advances in targeted therapy for pancreatic cancer
Lin Xing, Linlin Lv, Jiaqi Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115717-115717
Open Access | Times Cited: 15
Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application
Yang Chen, Rui Liang, Yong Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Integrating CRISPR Technology with Key Genetic Markers in Pancreatic Cancer: A New Frontier in Targeted Therapies
Dimitrios Stefanoudakis
SynBio (2025) Vol. 3, Iss. 1, pp. 1-1
Open Access
A Mutual Interaction Between GSTP1 and p53 Improves the Drug Resistance and Malignant Biology of Pancreatic Cancer
Guosen Wang, Yi Cao, Tengcheng Hu, et al.
Cancer Science (2025)
Open Access
Decoding YOD1: Insights into tumour regulation and translational opportunities
Zhi Xiong Chong
Biochemical Pharmacology (2025), pp. 116889-116889
Closed Access
MicroRNA electrochemical biosensors for pancreatic cancer
Fereshteh Rahdan, Fateme Bina, Elham Norouz Dolatabadi, et al.
Clinica Chimica Acta (2023) Vol. 548, pp. 117472-117472
Closed Access | Times Cited: 9
Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential
Khem Raj Limbu, Rashmi Bhandari Chhetri, Su-Bin Kim, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Drug-Induced p53 Activation Promotes Acinar Cell Identity and Prevents Pancreatic Cancer Initiation
Jennifer J. Twardowski, Thomas I. Heist, Zamira Guerra Soares, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Unlocking the Gateway: The Spatio-Temporal Dynamics of the p53 Family Driven by the Nuclear Pores and Its Implication for the Therapeutic Approach in Cancer
Dini Kurnia Ikliptikawati, Kei Makiyama, Masaharu Hazawa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7465-7465
Open Access | Times Cited: 1
Honey Targets Ribosome Biogenesis Components to Suppress the Growth of Human Pancreatic Cancer Cells
Aun Ali Bangash, Sahir Sultan Alvi, Muhammad Bangash, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3431-3431
Open Access | Times Cited: 1
From precursor to cancer: decoding the intrinsic and extrinsic pathways of pancreatic intraepithelial neoplasia progression
Sarah E. Graham, Mariia Dmitrieva, Débora B. Vendramini‐Costa, et al.
Carcinogenesis (2024) Vol. 45, Iss. 11, pp. 801-816
Closed Access | Times Cited: 1
Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy
Umm e Laila, Wang An, Zhi-Xiang Xu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Network Toxicology and Molecular Docking Analysis of Tetracycline-Induced Acute Pancreatitis: Unveiling Core Mechanisms and Targets
Hang Lei, Yan Wu, Wenjun Ma, et al.
Toxics (2024) Vol. 12, Iss. 12, pp. 929-929
Open Access | Times Cited: 1
SSH3 promotes pancreatic cancer proliferation and migration by activating the notch signaling pathway
Chengxiao Yang
American Journal of Cancer Research (2024) Vol. 14, Iss. 4, pp. 1815-1830
Open Access
Systematic review and meta-analysis of relationship between p53 protein expression and lymph node metastasis, vascular invasion, and perineural invasion in pancreatic cancer
Minghao Jia, Shilei Zhang, Tiebing Liu, et al.
Shijie huaren xiaohua zazhi (2024) Vol. 32, Iss. 5, pp. 376-386
Open Access
SAHA/5-AZA Enhances Acetylation and Degradation of mutp53, Upregulates p21 and Downregulates c-Myc and BRCA-1 in Pancreatic Cancer Cells
Michele Di Crosta, Francesca Chiara Ragone, Rossella Benedetti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7020-7020
Open Access
Analyzing the Role of Time Series Analysis in Early Detection of Pancreatic Cancer
R. Kavitha, Yashvardhan Singh, M. V. Madhusudhan, et al.
Lecture notes in electrical engineering (2024), pp. 582-587
Closed Access
Identification of molecular and functional subtypes using chronic pancreatitis patient-derived organoid models
Victoria Osorio-Vasquez, Jan Lumibao, Kristina Peck, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Proteomic biomarkers profiling in Pakistani pancreatic ductal adenocarcinoma population: a retrospective cohort study
Saleema Mehboob Ali, Adnan Ali, Zubair Ahmad, et al.
Biomarkers in Medicine (2024), pp. 1-14
Closed Access
Page 1

Scroll to top